Literature DB >> 10450253

Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex.

J Wu1, M S Buchsbaum, J C Gillin, C Tang, S Cadwell, M Wiegand, A Najafi, E Klein, K Hazen, W E Bunney, J H Fallon, D Keator.   

Abstract

OBJECTIVE: Sleep deprivation has been shown to have an antidepressant benefit in a subgroup of depressed patients. Functional imaging studies by the authors and others have suggested that patients with elevated metabolic rates in the anterior cingulate gyrus at baseline are more likely to respond to either sleep deprivation or antidepressant medications than patients with normal metabolic rates. The authors extend their earlier work in a larger group of patients and explore additional brain areas with statistical probability mapping.
METHOD: Thirty-six patients with unipolar depression and 26 normal volunteers were studied with positron emission tomography before and after sleep deprivation. Response to sleep deprivation was defined as a 40% or larger decrease in total scores on the Hamilton Depression Rating Scale.
RESULTS: One-third of the depressed patients had a significant response to sleep deprivation. Responders had higher relative metabolic rates in the medial prefrontal cortex, ventral anterior cingulate, and posterior subcallosal gyrus at baseline than depressed patients who did not respond to sleep deprivation and normal volunteers. Lower Hamilton depression scores correlated significantly with lower metabolic rates in the left medial prefrontal cortex. After sleep deprivation, significant decreases in metabolic rates occurred in the medial prefrontal cortex and frontal pole in the patients who responded positively to sleep deprivation.
CONCLUSIONS: High pretreatment metabolic rates and decreases in metabolic rates after treatment in the medial prefrontal cortex may characterize a subgroup of depressed patients who improve following sleep deprivation and, perhaps, other antidepressant treatments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450253     DOI: 10.1176/ajp.156.8.1149

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  73 in total

1.  Posterior cingulate cortex activation by emotional words: fMRI evidence from a valence decision task.

Authors:  Richard J Maddock; Amy S Garrett; Michael H Buonocore
Journal:  Hum Brain Mapp       Date:  2003-01       Impact factor: 5.038

2.  Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.

Authors:  Anita J Bechtholt-Gompf; Hali V Walther; Martha A Adams; William A Carlezon; Dost Ongür; Bruce M Cohen
Journal:  Neuropsychopharmacology       Date:  2010-06-09       Impact factor: 7.853

Review 3.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

4.  Does amygdalar perfusion correlate with antidepressant response to partial sleep deprivation in major depression?

Authors:  Camellia P Clark; Gregory G Brown; Sarah L Archibald; Christine Fennema-Notestine; Deborah R Braun; Linda S Thomas; Ashley N Sutherland; J Christian Gillin
Journal:  Psychiatry Res       Date:  2005-12-27       Impact factor: 3.222

5.  The functional neuroanatomy of geriatric depression.

Authors:  Gwenn S Smith; Elisse Kramer; Yilong Ma; Peter Kingsley; Vijay Dhawan; Thomas Chaly; David Eidelberg
Journal:  Int J Geriatr Psychiatry       Date:  2009-08       Impact factor: 3.485

6.  Sleep deprivation increases dorsal nexus connectivity to the dorsolateral prefrontal cortex in humans.

Authors:  Oliver G Bosch; Julia S Rihm; Milan Scheidegger; Hans-Peter Landolt; Philipp Stämpfli; Janis Brakowski; Fabrizio Esposito; Björn Rasch; Erich Seifritz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

7.  Neural correlates of inhibitory deficits in depression.

Authors:  Fanny Eugène; Jutta Joormann; Rebecca E Cooney; Lauren Y Atlas; Ian H Gotlib
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

8.  Pretreatment brain states identify likely nonresponse to standard treatments for depression.

Authors:  Callie L McGrath; Mary E Kelley; Boadie W Dunlop; Paul E Holtzheimer; W Edward Craighead; Helen S Mayberg
Journal:  Biol Psychiatry       Date:  2013-12-19       Impact factor: 13.382

9.  Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.

Authors:  Jakub Z Konarski; Sidney H Kennedy; Zindel V Segal; Mark A Lau; Peter J Bieling; Roger S McIntyre; Helen S Mayberg
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

10.  Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

Authors:  Matthew S Milak; Ramin V Parsey; Leilani Lee; Maria A Oquendo; Doreen M Olvet; Francoise Eipper; Kevin Malone; J John Mann
Journal:  Psychiatry Res       Date:  2009-05-14       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.